| Financial Year |
March 31 2023 |
| Monetary Funds |
5,800,297,559.03 |
| Held-for-trading Financial Assets |
5,630,130.92 |
| Notes Receivable |
579,994,954.55 |
| Accounts Receivable |
3,321,334,397.99 |
| Advances to Suppliers |
547,977,538.34 |
| Other Receivables |
45,567,832.69 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
7,000,000.00 |
| Inventories |
3,302,225,919.68 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
30,211.25 |
| Other Current Assets |
209,650,906.89 |
| Total Current Assets |
16,693,617,734.81 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
220,677.88 |
| Long-term Equity Investment |
190,321,411.30 |
| Investment Properties |
28,730,489.23 |
| Fixed Assetes |
1,428,701,073.07 |
| Under-construction Projects |
582,289,227.73 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
200,221,067.19 |
| R&D expenses |
-- |
| Goodwill |
11,722,785.64 |
| Long-Term Deferred and Prepaid Expenses |
804,191,514.95 |
| Deferred Income Tax Assets |
134,238,110.65 |
| Other Non-Current Assets |
25,830,539.72 |
| Sub-Total of Non-Current Assets |
4,070,236,959.29 |
| Total Assets |
20,763,854,694.10 |
| Short-Term Loans |
148,128,291.96 |
| Trading Financial liabilities |
-- |
| Notes Payable |
459,119,034.77 |
| Accounts Payable |
3,750,477,177.15 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
242,165,336.26 |
| Taxes Payable |
31,304,016.27 |
| Interest Payable |
-- |
| Dividend Payable |
2,450,000.00 |
| Other payables |
840,904,733.81 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
66,708,239.33 |
| Other Current Liabilities |
64,357,008.33 |
| Sub-Total of Current Liabilities |
9,057,330,499.31 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
6,000,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
17,509,801.46 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
471,214,448.64 |
| Total Liabilities |
9,528,544,947.95 |
| Paid-In Capital(Or Share Stock) |
2,002,158,781.00 |
| Capital Surplus |
3,803,825,027.86 |
| Surplus Reserve |
940,426,247.28 |
| LESS:Treasury Stock |
743,936,864.79 |
| Undistributed Profits |
4,504,411,113.44 |
| Minority Stockholder's Interest |
732,750,574.12 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
10,502,559,172.03 |
| Owner's Equity（Stockholder's Equity） |
11,235,309,746.15 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
20,763,854,694.10 |
